Allgens(SH:688613) Zheng Quan Zhi Xing·2025-07-11 16:13Core Viewpoint - The legal opinion letter confirms that the procedures for convening and holding the 2025 first extraordinary general meeting of shareholders of Aojing Medical Technology Co., Ltd. comply with relevant laws and regulations [1][5][6]. Group 1: Meeting Procedures - The company published the notice for the extraordinary general meeting on June 26, 2025, which included details such as meeting time, voting methods, and agenda items, with a notice period of 15 days before the meeting [2][3]. - The meeting was held on July 11, 2025, at a specified location, and was presided over by the company's chairman, Eric Gang Hu [3]. Group 2: Attendance and Qualifications - A total of 89 shareholders and authorized agents attended the meeting, holding 26,135,097 shares, which represents a significant portion of the voting rights as of the registration date [5][6]. - The qualifications of the attendees and the convenor of the meeting were verified to be in accordance with the relevant laws and the company's articles of association [5][6]. Group 3: Voting Procedures and Results - The voting process combined both on-site and online methods, with results being counted and announced immediately after the meeting [7]. - The meeting approved the agenda items as listed in the notice, and there were no objections raised regarding the voting results [7]. Group 4: Conclusion - The legal opinion concludes that all aspects of the meeting, including convening, attendance, and voting procedures, were conducted in compliance with applicable laws and regulations, rendering the results valid [5][7].